Peptides and Heparin Market

Peptides and Heparin Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

Analysis of Peptides and Heparin market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Introduction

Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size.

Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products.

However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains.

Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses.

For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed.

In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals.

The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules.

Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

A new report by Fact.MR projects the global peptide and heparin market to reflect an impressive expansion during the forecast period, 2017 to 2026. Revenues from the market are estimated to exceed US$ 34,000 Mn by 2026-end.

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ).

Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region.

In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

  • Oral route of administration will remain preferred for peptide and heparin
  • Cancer will continue to be the dominant indication segment in the market, in terms of revenues
  • Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors.

These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas.

Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future.

Key market participants identified by the report include

  • Baxter
  • Celsus
  • Biofer S.p.A,
  • Hemmo Pharma
  • AmbioPharm Inc.
  • Wockhardt Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Bachem
  • Abbott Laboratories
  • Pfizer Inc
  • Aspen
  • Leo Pharma
  • Teva
  • Takeda
  • Sanofi
  • Novo Nordisk
  • Eli Lilly.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Market Taxonomy

  • By Region:

    • North America
    • Latin America
    • Europe
    • Japan
    • APEJ
    • MEA

  • By Product Type:

    • Sodium Heparin
    • Ammonium Heparin
    • lithium Heparin
    • Icatibant
    • Bivalirudin
    • Liraglutide
    • Exenatide
    • Goserelin
    • Bortezomib
    • Other Product Types

  • By Route of Administration:

    • Intravenous
    • Oral Route
    • Others

  • By Indication:

    • Diabetes
    • Cardiovascular
    • Cancer
    • Metabolic Disorder
    • Central Nervous Systems
    • Other Indications

  • By Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Table of Content

  • 1. Global Economic Outlook
  • 2. Global Market - Executive Summary
  • 3. Global Market Overview
  • 4. Global Market Analysis and Forecast 2012 to 2026
    • 4.1. Global Market Size and Forecast By Product Type, 2012 to 2026
      • 4.1.1. Sodium Heparin
      • 4.1.2. Ammonium Heparin
      • 4.1.3. Lithium Heparin
      • 4.1.4. Icatibant
      • 4.1.5. Bivalirudin
      • 4.1.6. Liraglutide
      • 4.1.7. Exenatide
      • 4.1.8. Goserelin
      • 4.1.9. Bortezomib
      • 4.1.10. Other Product Types
    • 4.2. Global Market Size and Forecast By Route of Administration, 2012 to 2026
      • 4.2.1. Intravenous
      • 4.2.2. Oral Route
      • 4.2.3. Others
    • 4.3. Global Market Size and Forecast By Indication, 2012 to 2026
      • 4.3.1. Diabetes
      • 4.3.2. Cardiovascular
      • 4.3.3. Cancer
      • 4.3.4. Metabolic Disorder
      • 4.3.5. Central Nervous Systems
      • 4.3.6. Other Indications
    • 4.4. Global Market Size and Forecast By Distribution Channel, 2012 to 2026
      • 4.4.1. Hospital Pharmacies
      • 4.4.2. Retail Pharmacies
      • 4.4.3. Online Pharmacies
  • 5. North America Market Size and Forecast, 2012 to 2026
  • 6. Latin America Market Size and Forecast, 2012 to 2026
  • 7. Europe Market Size and Forecast, 2012 to 2026
  • 8. Japan Market Size and Forecast, 2012 to 2026
  • 9. APEJ Market Size and Forecast, 2012 to 2026
  • 10. MEA Market Size and Forecast, 2012 to 2026
  • 11. Global Market Company Share, Competition Landscape and Company Profiles
    • 11.1. Eli Lilly
    • 11.2. Novo Nordisk
    • 11.3. Sanofi
    • 11.4. Takeda
    • 11.5. Teva
    • 11.6. Leo Pharma
    • 11.7. Aspen
    • 11.8. Pfizer Inc.
    • 11.9. Abbott Laboratories
    • 11.10. Bachem
    • 11.11. Sun Pharmaceutical Industries Ltd
    • 11.12. Wockhardt Ltd.
    • 11.13. AmbioPharm, Inc
    • 11.14. Hemmo Pharma
    • 11.15. Biofer S.p.A
    • 11.16. Other Key Players
  • 12. Research Methodology
  • 13. Disclaimer

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Market Value (US$ Mn), 2012 to 2017

TABLE 2 Global Market Value (US$ Mn), 2018 to 2026

TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2026

TABLE 4 Global Sodium Heparin Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 5 Global Sodium Heparin Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 6 Global Sodium Heparin Segment Market Share, By Region 2012 to 2017

TABLE 7 Global Sodium Heparin Segment Market Share, By Region 2018 to 2026

TABLE 8 Global Sodium Heparin Segment Y-o-Y, By Region 2017 to 2026

TABLE 9 Global Ammonium Heparin Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 10 Global Ammonium Heparin Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 11 Global Ammonium Heparin Segment Market Share, By Region 2012 to 2017

TABLE 12 Global Ammonium Heparin Segment Market Share, By Region 2018 to 2026

TABLE 13 Global Ammonium Heparin Segment Y-o-Y, By Region 2017 to 2026

TABLE 14 Global lithium Heparin Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 15 Global lithium Heparin Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 16 Global lithium Heparin Segment Market Share, By Region 2012 to 2017

TABLE 17 Global lithium Heparin Segment Market Share, By Region 2018 to 2026

TABLE 18 Global lithium Heparin Segment Y-o-Y, By Region 2017 to 2026

TABLE 19 Global Icatibant Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 20 Global Icatibant Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 21 Global Icatibant Segment Market Share, By Region 2012 to 2017

TABLE 22 Global Icatibant Segment Market Share, By Region 2018 to 2026

TABLE 23 Global Icatibant Segment Y-o-Y, By Region 2017 to 2026

TABLE 24 Global Bivalirudin Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 25 Global Bivalirudin Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 26 Global Bivalirudin Segment Market Share, By Region 2012 to 2017

TABLE 27 Global Bivalirudin Segment Market Share, By Region 2018 to 2026

TABLE 28 Global Bivalirudin Segment Y-o-Y, By Region 2017 to 2026

TABLE 29 Global Liraglutide Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 30 Global Liraglutide Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 31 Global Liraglutide Segment Market Share, By Region 2012 to 2017

TABLE 32 Global Liraglutide Segment Market Share, By Region 2018 to 2026

TABLE 33 Global Liraglutide Segment Y-o-Y, By Region 2017 to 2026

TABLE 34 Global Exenatide Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 35 Global Exenatide Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 36 Global Exenatide Segment Market Share, By Region 2012 to 2017

TABLE 37 Global Exenatide Segment Market Share, By Region 2018 to 2026

TABLE 38 Global Exenatide Segment Y-o-Y, By Region 2017 to 2026

TABLE 39 Global Goserelin Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 40 Global Goserelin Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 41 Global Goserelin Segment Market Share, By Region 2012 to 2017

TABLE 42 Global Goserelin Segment Market Share, By Region 2018 to 2026

TABLE 43 Global Goserelin Segment Y-o-Y, By Region 2017 to 2026

TABLE 44 Global Bortezomib Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 45 Global Bortezomib Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 46 Global Bortezomib Segment Market Share, By Region 2012 to 2017

TABLE 47 Global Bortezomib Segment Market Share, By Region 2018 to 2026

TABLE 48 Global Bortezomib Segment Y-o-Y, By Region 2017 to 2026

TABLE 49 Global Other Product Types Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 50 Global Other Product Types Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 51 Global Other Product Types Segment Market Share, By Region 2012 to 2017

TABLE 52 Global Other Product Types Segment Market Share, By Region 2018 to 2026

TABLE 53 Global Other Product Types Segment Y-o-Y, By Region 2017 to 2026

TABLE 54 Global Intravenous Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 55 Global Intravenous Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 56 Global Intravenous Segment Market Share, By Region 2012 to 2017

TABLE 57 Global Intravenous Segment Market Share, By Region 2018 to 2026

TABLE 58 Global Intravenous Segment Y-o-Y, By Region 2017 to 2026

TABLE 59 Global Oral Route Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 60 Global Oral Route Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 61 Global Oral Route Segment Market Share, By Region 2012 to 2017

TABLE 62 Global Oral Route Segment Market Share, By Region 2018 to 2026

TABLE 63 Global Oral Route Segment Y-o-Y, By Region 2017 to 2026

TABLE 64 Global Others Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 65 Global Others Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 66 Global Others Segment Market Share, By Region 2012 to 2017

TABLE 67 Global Others Segment Market Share, By Region 2018 to 2026

TABLE 68 Global Others Segment Y-o-Y, By Region 2017 to 2026

TABLE 69 Global Diabetes Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 70 Global Diabetes Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 71 Global Diabetes Segment Market Share, By Region 2012 to 2017

TABLE 72 Global Diabetes Segment Market Share, By Region 2018 to 2026

TABLE 73 Global Diabetes Segment Y-o-Y, By Region 2017 to 2026

TABLE 74 Global Cardiovascular Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 75 Global Cardiovascular Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 76 Global Cardiovascular Segment Market Share, By Region 2012 to 2017

TABLE 77 Global Cardiovascular Segment Market Share, By Region 2018 to 2026

TABLE 78 Global Cardiovascular Segment Y-o-Y, By Region 2017 to 2026

TABLE 79 Global Cancer Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 80 Global Cancer Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 81 Global Cancer Segment Market Share, By Region 2012 to 2017

TABLE 82 Global Cancer Segment Market Share, By Region 2018 to 2026

TABLE 83 Global Cancer Segment Y-o-Y, By Region 2017 to 2026

TABLE 84 Global Metabolic Disorder Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 85 Global Metabolic Disorder Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 86 Global Metabolic Disorder Segment Market Share, By Region 2012 to 2017

TABLE 87 Global Metabolic Disorder Segment Market Share, By Region 2018 to 2026

TABLE 88 Global Metabolic Disorder Segment Y-o-Y, By Region 2017 to 2026

TABLE 89 Global Central Nervous Systems Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 90 Global Central Nervous Systems Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 91 Global Central Nervous Systems Segment Market Share, By Region 2012 to 2017

TABLE 92 Global Central Nervous Systems Segment Market Share, By Region 2018 to 2026

TABLE 93 Global Central Nervous Systems Segment Y-o-Y, By Region 2017 to 2026

TABLE 94 Global Other Indications Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 95 Global Other Indications Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 96 Global Other Indications Segment Market Share, By Region 2012 to 2017

TABLE 97 Global Other Indications Segment Market Share, By Region 2018 to 2026

TABLE 98 Global Other Indications Segment Y-o-Y, By Region 2017 to 2026

TABLE 99 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 100 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 101 Global Hospital Pharmacies Segment Market Share, By Region 2012 to 2017

TABLE 102 Global Hospital Pharmacies Segment Market Share, By Region 2018 to 2026

TABLE 103 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017 to 2026

TABLE 104 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 105 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 106 Global Retail Pharmacies Segment Market Share, By Region 2012 to 2017

TABLE 107 Global Retail Pharmacies Segment Market Share, By Region 2018 to 2026

TABLE 108 Global Retail Pharmacies Segment Y-o-Y, By Region 2017 to 2026

TABLE 109 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012 to 2017

TABLE 110 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018 to 2026

TABLE 111 Global Online Pharmacies Segment Market Share, By Region 2012 to 2017

TABLE 112 Global Online Pharmacies Segment Market Share, By Region 2018 to 2026

TABLE 113 Global Online Pharmacies Segment Y-o-Y, By Region 2017 to 2026

TABLE 114 North America Market Value (US$ Mn), By Country 2012 to 2017

TABLE 115 North America Market Value (US$ Mn), By Country 2018 to 2026

TABLE 116 North America Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 117 North America Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 118 North America Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 119 North America Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 120 North America Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 121 North America Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 122 North America Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 123 North America Market Value (US$ Mn), By Distribution Channel2018 to 2026

TABLE 124 Latin America Market Value (US$ Mn), By Country 2012 to 2017

TABLE 125 Latin America Market Value (US$ Mn), By Country 2018 to 2026

TABLE 126 Latin America Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 127 Latin America Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 128 Latin America Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 129 Latin America Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 130 Latin America Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 131 Latin America Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 132 Latin America Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 133 Latin America Market Value (US$ Mn), By Distribution Channel2018 to 2026

TABLE 134 Europe Market Value (US$ Mn), By Country 2012 to 2017

TABLE 135 Europe Market Value (US$ Mn), By Country 2018 to 2026

TABLE 136 Europe Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 137 Europe Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 138 Europe Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 139 Europe Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 140 Europe Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 141 Europe Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 142 Europe Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 143 Europe Market Value (US$ Mn), By Distribution Channel2018 to 2026

TABLE 144 Japan Market Value (US$ Mn), By Country 2012 to 2017

TABLE 145 Japan Market Value (US$ Mn), By Country 2018 to 2026

TABLE 146 Japan Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 147 Japan Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 148 Japan Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 149 Japan Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 150 Japan Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 151 Japan Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 152 Japan Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 153 Japan Market Value (US$ Mn), By Distribution Channel2018 to 2026

TABLE 154 APEJ Market Value (US$ Mn), By Country 2012 to 2017

TABLE 155 APEJ Market Value (US$ Mn), By Country 2018 to 2026

TABLE 156 APEJ Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 157 APEJ Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 158 APEJ Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 159 APEJ Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 160 APEJ Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 161 APEJ Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 162 APEJ Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 163 APEJ Market Value (US$ Mn), By Distribution Channel2018 to 2026

TABLE 164 MEA Market Value (US$ Mn), By Country 2012 to 2017

TABLE 165 MEA Market Value (US$ Mn), By Country 2018 to 2026

TABLE 166 MEA Market Value (US$ Mn), By Product Type 2012 to 2017

TABLE 167 MEA Market Value (US$ Mn), By Product Type 2018 to 2026

TABLE 168 MEA Market Value (US$ Mn), By Route of Administration 2012 to 2017

TABLE 169 MEA Market Value (US$ Mn), By Route of Administration 2018 to 2026

TABLE 170 MEA Market Value (US$ Mn), By Indication 2012 to 2017

TABLE 171 MEA Market Value (US$ Mn), By Indication 2018 to 2026

TABLE 172 MEA Market Value (US$ Mn), By Distribution Channel2012 to 2017

TABLE 173 MEA Market Value (US$ Mn), By Distribution Channel2018 to 2026

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Market Value (US$ Mn), 2012 to 2017

FIG. 2 Global Market Value (US$ Mn) Forecast, 2018 to 2026

FIG. 3 Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2026

FIG. 4 Global Sodium Heparin Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 5 Global Sodium Heparin Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 6 Global Sodium Heparin Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 7 Global Ammonium Heparin Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 8 Global Ammonium Heparin Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 9 Global Ammonium Heparin Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 10 Global lithium Heparin Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 11 Global lithium Heparin Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 12 Global lithium Heparin Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 13 Global Icatibant Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 14 Global Icatibant Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 15 Global Icatibant Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 16 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 17 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 18 Global Bivalirudin Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 19 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 20 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 21 Global Liraglutide Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 22 Global Exenatide Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 23 Global Exenatide Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 24 Global Exenatide Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 25 Global Goserelin Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 26 Global Goserelin Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 27 Global Goserelin Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 28 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 29 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 30 Global Bortezomib Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 31 Global Other Product Types Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 32 Global Other Product Types Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 33 Global Other Product Types Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 34 Global Intravenous Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 35 Global Intravenous Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 36 Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 37 Global Oral Route Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 38 Global Oral Route Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 39 Global Oral Route Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 40 Global Others Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 41 Global Others Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 42 Global Others Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 43 Global Diabetes Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 44 Global Diabetes Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 45 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 46 Global Cardiovascular Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 47 Global Cardiovascular Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 48 Global Cardiovascular Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 49 Global Cancer Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 50 Global Cancer Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 51 Global Cancer Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 52 Global Metabolic Disorder Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 53 Global Metabolic Disorder Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 54 Global Metabolic Disorder Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 55 Global Central Nervous Systems Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 56 Global Central Nervous Systems Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 57 Global Central Nervous Systems Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 58 Global Other Indications Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 59 Global Other Indications Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 60 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 61 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 62 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 63 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 64 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 65 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 66 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 67 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012 to 2017

FIG. 68 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018 to 2026

FIG. 69 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017 to 2026

FIG. 70 North America Market Value (US$ Mn), By Country 2012 to 2017

FIG. 71 North America Market Value (US$ Mn), By Country 2018 to 2026

FIG. 72 North America Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 73 North America Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 74 North America Market Value (US$ Mn), By Route of Administration 2012 to 2017

FIG. 75 North America Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 76 North America Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 77 North America Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 78 North America Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 79 North America Market Value (US$ Mn), By Distribution Channel2018 to 2026

FIG. 80 Latin America Market Value (US$ Mn), By Country 2012 to 2017

FIG. 81 Latin America Market Value (US$ Mn), By Country 2018 to 2026

FIG. 82 Latin America Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 83 Latin America Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 84 Latin America Market Value (US$ Mn), By Route of Administration 2012 to 2017

FIG. 85 Latin America Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 86 Latin America Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 87 Latin America Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 88 Latin America Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 89 Latin America Market Value (US$ Mn), By Distribution Channel2018 to 2026

FIG. 90 Europe Market Value (US$ Mn), By Country 2012 to 2017

FIG. 91 Europe Market Value (US$ Mn), By Country 2018 to 2026

FIG. 92 Europe Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 93 Europe Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 94 Europe Market Value (US$ Mn), By Route of Administration 2012 to 2017

FIG. 95 Europe Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 96 Europe Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 97 Europe Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 98 Europe Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 99 Europe Market Value (US$ Mn), By Distribution Channel2018 to 2026

FIG. 100 Japan Market Value (US$ Mn), By Country 2012 to 2017

FIG. 101 Japan Market Value (US$ Mn), By Country 2018 to 2026

FIG. 102 Japan Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 103 Japan Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 104 Japan Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 105 Japan Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 106 Japan Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 107 Japan Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 108 Japan Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 109 Japan Market Value (US$ Mn), By Distribution Channel2018 to 2026

FIG. 110 APEJ Market Value (US$ Mn), By Country 2012 to 2017

FIG. 111 APEJ Market Value (US$ Mn), By Country 2018 to 2026

FIG. 112 APEJ Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 113 APEJ Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 114 APEJ Market Value (US$ Mn), By Route of Administration 2012 to 2017

FIG. 115 APEJ Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 116 APEJ Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 117 APEJ Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 118 APEJ Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 119 APEJ Market Value (US$ Mn), By Distribution Channel2018 to 2026

FIG. 120 MEA Market Value (US$ Mn), By Country 2012 to 2017

FIG. 121 MEA Market Value (US$ Mn), By Country 2018 to 2026

FIG. 122 MEA Market Value (US$ Mn), By Product Type 2012 to 2017

FIG. 123 MEA Market Value (US$ Mn), By Product Type 2018 to 2026

FIG. 124 MEA Market Value (US$ Mn), By Route of Administration 2012 to 2017

FIG. 125 MEA Market Value (US$ Mn), By Route of Administration 2018 to 2026

FIG. 126 MEA Market Value (US$ Mn), By Indication 2012 to 2017

FIG. 127 MEA Market Value (US$ Mn), By Indication 2018 to 2026

FIG. 128 MEA Market Value (US$ Mn), By Distribution Channel2012 to 2017

FIG. 129 MEA Market Value (US$ Mn), By Distribution Channel2018 to 2026

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the anticipated market value for Peptides and Heparin in 2026?

The Peptides and Heparin Market is likely to acquire a global market share of US$ 34,000 Mn by the end of 2026.

Who are the prominent Peptides and Heparin market players?

Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem are prominent Peptides and Heparin market players.

Peptides and Heparin Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services